Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Cras

Showing results (121-130 of 179) with videos related to

Pageof 18
Sort By:
Journal of Alzheimer'S Disease : JAD|August 29, 2016
A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in BelgiumCharisse Somers, Hanne Struyfs, Joery Goossens, et al.
European Journal of Human Genetics : EJHG|January 17, 2008
Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patientsKaren Nuytemans, Rosa Rademakers, Jessie Theuns, et al.
Neurobiology of Aging|September 14, 2020
No association of CpG SNP rs9357140 with onset age in Belgian C9orf72 repeat expansion carriersCemile Koçoğlu, Helena Gossye, Lubina Dillen, et al.
Neurobiology of Aging|February 17, 2012
Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian populationAline Verstraeten, Eline Wauters, David Crosiers, et al.
Cytotherapy|May 27, 2014
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controlsAmber H Nuyts, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Neurobiology of Aging|January 15, 2013
Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patientsLubina Dillen, Tim Van Langenhove, Sebastiaan Engelborghs, et al.
Neurobiology of Aging|November 29, 2011
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?Bram Meeus, Aline Verstraeten, David Crosiers, et al.
Molecular Psychiatry|July 11, 2023
Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protectionRita Cacace, Lujia Zhou, Elisabeth Hendrickx Van de Craen, et al.
Human Mutation|May 1, 2009
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian populationKaren Nuytemans, Bram Meeus, David Crosiers, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degenerationJoery Goossens, Maria Bjerke, Sara Van Mossevelde, et al.
Pageof 18

Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
Journal of Alzheimer'S Disease : JAD|August 29, 2016
A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in BelgiumCharisse Somers, Hanne Struyfs, Joery Goossens, et al.
European Journal of Human Genetics : EJHG|January 17, 2008
Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patientsKaren Nuytemans, Rosa Rademakers, Jessie Theuns, et al.
Neurobiology of Aging|September 14, 2020
No association of CpG SNP rs9357140 with onset age in Belgian C9orf72 repeat expansion carriersCemile Koçoğlu, Helena Gossye, Lubina Dillen, et al.
Neurobiology of Aging|February 17, 2012
Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian populationAline Verstraeten, Eline Wauters, David Crosiers, et al.
Cytotherapy|May 27, 2014
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controlsAmber H Nuyts, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Neurobiology of Aging|January 15, 2013
Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patientsLubina Dillen, Tim Van Langenhove, Sebastiaan Engelborghs, et al.
Neurobiology of Aging|November 29, 2011
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?Bram Meeus, Aline Verstraeten, David Crosiers, et al.
Molecular Psychiatry|July 11, 2023
Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protectionRita Cacace, Lujia Zhou, Elisabeth Hendrickx Van de Craen, et al.
Human Mutation|May 1, 2009
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian populationKaren Nuytemans, Bram Meeus, David Crosiers, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degenerationJoery Goossens, Maria Bjerke, Sara Van Mossevelde, et al.
Pageof 18